Schedule 13G ownership disclosure

Atossa Therapeutics Inc

Security class unavailable · CUSIP: 04962H506

Event date: 2021-01-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,800,000
Percent of class
5.3200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-21-000205
Form type
SC 13G
Filer
ATOSSA THERAPEUTICS, INC.
CIK
CIK 1488039
Filed
Jan 14, 2021
Reporting period
Jan 06, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub